Global gRNA Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global gRNA Market was valued at $710 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 18.8% CAGR, to an estimated market size of $1.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global gRNA market encompasses the synthesis, design, and supply of guide RNA molecules, including crRNA and tracrRNA, which serve as the navigational components of CRISPR-Cas systems to direct nucleases to precise genomic loci for genome editing. The scope includes synthetic gRNA, in-vitro transcribed (IVT) gRNA, and plasmid-encoded constructs used in biomedical research, therapeutic development, and agricultural biotechnology.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the gRNA Market in the period 2025-30:
- The expansion of the therapeutic pipeline, with over 85 active CRISPR trials, is significantly driving demand for high-quality GMP-grade materials.
- AI-driven design platforms are increasingly utilized to optimize gRNA sequences, predict target efficiency, and minimize off-target effects.
- A transition toward platformized workflows is occurring, moving away from commodity reagents toward high-fidelity nucleases and RNP-based delivery.
- Technological advancements in enzymatic synthesis and chemical modifications are reducing production costs and improving gRNA stability.
- The regulatory validation provided by the first FDA-approved CRISPR therapies has spurred a new cycle of procurement and investment in precision medicine.
- Agricultural biotechnology is emerging as a significant long-term driver as gene editing is applied to crop improvement and pest resistance in global markets.
- The rising adoption of multiplexing allows for the simultaneous editing of multiple genomic loci, accelerating functional genomics and drug discovery.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Research-use Grade
- GMP-grade